Cargando…
The Cost and Utility of Renal Transplantation in Malaysia
Kidney transplantation is the optimal therapy for the majority of patients with end-stage renal disease. However, the cost and health outcomes of transplantation have not been assessed in a middle-income nation with a low volume of transplantation, such as Malaysia. AIM AND METHODS: This study used...
Autores principales: | Bavanandan, Sunita, Yap, Yok-Chin, Ahmad, Ghazali, Wong, Hin-Seng, Azmi, Soraya, Goh, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946449/ https://www.ncbi.nlm.nih.gov/pubmed/27500211 http://dx.doi.org/10.1097/TXD.0000000000000553 |
Ejemplares similares
-
Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040
por: Bujang, Mohamad Adam, et al.
Publicado: (2017) -
Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis
por: Surendra, Naren Kumar, et al.
Publicado: (2019) -
Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study
por: Lee, Fei Yee, et al.
Publicado: (2021) -
Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease
por: Yugavathy, Nava, et al.
Publicado: (2023) -
Adverse Drug Reactions of Antihypertensives and CYP3A5*3 Polymorphism Among Chronic Kidney Disease Patients
por: Lee, Fei Yee, et al.
Publicado: (2022)